Related Experiment Video
Updated: May 10, 2026

09:30
Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
Published on: October 4, 2016
Transcranial magnetic stimulation for treating depression in elderly patients
Gokben Hizli Sayar1, Eylem Ozten, Oguz Tan
1Uskudar University, Neuropsychiatry Istanbul Hospital, Department of Psychiatry, Istanbul, Turkey.
Neuropsychiatric Disease and Treatment
|June 1, 2013
Summary
High-frequency repetitive transcranial magnetic stimulation (rTMS) effectively treated depression in elderly patients. This safe, well-tolerated therapy improved mood and achieved remission in over half of participants, offering a valuable option for treatment-resistant cases.
Area of Science:
- Neuroscience
- Geriatric Psychiatry
- Clinical Therapeutics
Background:
- Depression is a significant health concern in the elderly population.
- Treatment-resistant depression (TRD) in older adults presents unique challenges.
- Exploring novel therapeutic interventions for geriatric depression is crucial.
Observation:
- Sixty-five elderly patients with depression received high-frequency repetitive transcranial magnetic stimulation (rTMS) over the left prefrontal cortex.
- Treatment involved daily sessions for three weeks, totaling approximately 1000 magnetic pulses per patient.
- The Hamilton Depression Rating Scale (HAMD) was used to assess depression severity before and after treatment.
Findings:
- Mean HAMD scores significantly decreased from 21.94 to 11.28 (P < 0.001) after rTMS.
- 58.46% of patients showed significant mood improvement (≥50% HAMD reduction), with 19 achieving remission (HAMD < 8).
- No patients experienced worsening of depression; treatment was well-tolerated with no serious adverse effects.
Implications:
- High-frequency rTMS is a safe and effective adjunctive treatment for elderly patients with treatment-resistant depression.
- This therapy demonstrates antidepressant effects in individuals over 60.
- rTMS offers a promising non-pharmacological option for improving mental health in geriatric populations.
